Companies with disruptive technologies always pop up on our radar. We keep a close eye on them until we start seeing some traction for their products, and then do a little more digging to see if the company has what it takes to be a Buzz Stock.
We’ve had our eye on Accuray, Inc. (Nasdaq: ARAY) for quite some time. The company’s non-invasive CyberKnife Robotic Radiosurgery System has received recognition from both physicians, and customers as of late.
Your browser does not support iframes.
On March 2, Accuray issued a news release that announced “increased interest and continued rapid growth” for CyberKnife. According to the announcement, the number of lung cancer patients treated with CyberKnife grew 52 percent from 2007-2008 in the U.S., and 43 percent worldwide. Additionally the overall number of patients treated with CyberKnife radiosurgery grew to more than 60,000 patients – a 14 percent increase from calendar year 2007 to 2008. In late February, the stock received a 5-star rating from members of the Motley Fool’s CAPS community. The Company has a CAGR of about 52 percent over the past two years and about $110 million of cash in the bank. Currently trading at around $4.00 a share, Accuray could be a good buy at these levels.
Check out this video on CyberKnife to get a better idea of why Accuray is our Buzz Stock of the day.
Tags: bargain stocks, biotech, buzz stocks, investing, technology